Soluble vascular cell adhesion molecule-1 and soluble E-selectin are associated with micro- and macrovascular complications in Type 1 diabetic patients

Journal of Diabetes and its Complications

Volumn 20, Issue 3, 2006, Pages 188-195

  Soedamah Muthu, Sabita S ^a,b   Chaturvedi, Nish ^c   Schalkwijk, Casper G ^d,e   Stehouwer, Coen D A ^d,e   Ebeling, Pertti ^f   Fuller, John H ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adhesion molecule; Albuminuria; Cardiovascular disease; Retinopathy; Type 1 diabetes; Vascular complications

Indexed keywords

ALBUMIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGE DISTRIBUTION; ALBUMINURIA; ANGINA PECTORIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CIGARETTE SMOKING; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORRELATION ANALYSIS; DATA ANALYSIS; DIABETIC ANGIOPATHY; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE DURATION; ELECTROCARDIOGRAM; FEMALE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PHOTOGRAPHY; PRIORITY JOURNAL; PROTEIN SECRETION; RISK FACTOR; SEX DIFFERENCE; STROKE; SYSTOLIC BLOOD PRESSURE;

ADULT; ALBUMINURIA; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; E-SELECTIN; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; RISK FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 33646032701     PISSN: 10568727     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jdiacomp.2005.06.005     Document Type: Article

References (41)

1. Albertini J.P., Valensi P., Lormeau B., et al. Elevated concentrations of soluble E-selectin and vascular cell adhesion molecule-1 in NIDDM. Effect of intensive insulin treatment. Diabetes Care 21 (1998) 1008-1013
2. Aldington S.J., Kohner E.M., Meuer S., Klein R., and Sjolie A.K. Methodology for retinal photography and assessment of diabetic retinopathy: The EURODIAB IDDM Complications Study. Diabetologia 38 (1995) 437-444
3. Bannan S., Mansfield M.W., and Grant P.J. Soluble vascular cell adhesion molecule-1 and E-selectin levels in relation to vascular risk factors and to E-selectin genotype in the first degree relatives of NIDDM patients and in NIDDM patients. Diabetologia 41 (1998) 460-466
4. Chaturvedi N., Bandinelli S., Mangili R., et al. Microalbuminuria in type 1 diabetes: Rates, risk factors and glycemic threshold. Kidney International 60 (2001) 219-227
5. Chaturvedi N., Fuller J.H., and Taskinen M.R. Differing associations of lipid and lipoprotein disturbances with the macrovascular and microvascular complications of type 1 diabetes. Diabetes Care 24 (2001) 2071-2077
6. Chaturvedi N., Schalkwijk C.G., Abrahamian H., Fuller J.H., and Stehouwer C.D. Circulating and urinary transforming growth factor beta1, Amadori albumin, and complications of type 1 diabetes: The EURODIAB Prospective Complications Study. Diabetes Care 25 (2002) 2320-2327
7. Clausen P., Jacobsen P., Rossing K., et al. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbuminuria and overt nephropathy. Diabetic Medicine 17 (2000) 644-649
8. Cominacini L., Fratta P.A., Garbin U., et al. Elevated levels of soluble E-selectin in patients with IDDM and NIDDM: Relation to metabolic control. Diabetologia 38 (1995) 1122-1124
9. Cominacini L., Fratta P.A., Garbin U., et al. E-selectin plasma concentration is influenced by glycaemic control in NIDDM patients: Possible role of oxidative stress. Diabetologia 40 (1997) 584-589
10. de Lemos J.A., Hennekens C.H., and Ridker P.M. Plasma concentration of soluble vascular cell adhesion molecule-1 and subsequent cardiovascular risk. Journal of the American College of Cardiology 36 (2000) 423-426
11. Elhadd T.A., Kennedy G., Hill A., et al. Abnormal markers of endothelial cell activation and oxidative stress in children, adolescents and young adults with type 1 diabetes with no clinical vascular disease. Diabetes/Metabolism Research and Reviews 15 (1999) 405-411
12. EURODIAB IDDM Complications Study group. Microvascular and acute complications in IDDM patients: The EURODIAB IDDM Complications Study. Diabetologia 37 (1994) 278-285
13. Fasching P., Veitl M., Rohac M., et al. Elevated concentrations of circulating adhesion molecules and their association with microvascular complications in insulin-dependent diabetes mellitus. Journal of Clinical Endocrinology and Metabolism 81 (1996) 4313-4317
14. Fasching P., Waldhausl W., and Wagner O.F. Elevated circulating adhesion molecules in NIDDM-Potential mediators in diabetic macroangiopathy. Diabetologia 39 (1996) 1242-1244
15. Fossati P., and Prencipe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clinical Chemistry 28 (1982) 2077-2080
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18 (1972) 499-502
17. Gearing A.J., and Newman W. Circulating adhesion molecules in disease. Immunology Today 14 (1993) 506-512
18. Hirata K., Shikata K., Matsuda M., et al. Increased expression of selectins in kidneys of patients with diabetic nephropathy. Diabetologia 41 (1998) 185-192
19. Huo Y., and Ley K. Adhesion molecules and atherogenesis. Acta Physiologica Scandinavica 173 (2001) 35-43
20. Jager A., van Hinsbergh V.W., Kostense P.J., et al. Increased levels of soluble vascular cell adhesion molecule 1 are associated with risk of cardiovascular mortality in type 2 diabetes: The Hoorn Study. Diabetes 49 (2000) 485-491
21. Jager A., van Hinsbergh V.W., Kostense P.J., et al. C-reactive protein and soluble vascular cell adhesion molecule-1 are associated with elevated urinary albumin excretion but do not explain its link with cardiovascular risk. Arteriosclerosis, Thrombosis, and Vascular Biology 22 (2002) 593-598
22. Jude E.B., Douglas J.T., Anderson S.G., Young M.J., and Boulton A.J.M. Circulating cellular adhesion molecules ICAM-1, VCAM-1, P- and E-selectin in the prediction of cardiovascular disease in diabetes mellitus. European Journal of Internal Medicine 13 (2002) 185-189
23. Kearney E.M., Mount J.N., Watts G.F., Slavin B.M., and Kind P.R. Simple immunoturbidimetric method for determining urinary albumin at low concentrations using Cobas-Bio centrifugal analyser. Journal of Clinical Pathology 40 (1987) 465-468
24. Knudsen S.T., Foss C.H., Poulsen P.L., et al. E-selectin-inducing activity in plasma from type 2 diabetic patients with maculopathy. American Journal of Physiology. Endocrinology and Metabolism 284 (2003) E1-E6
25. Koga M., Otsuki M., Kubo M., Hashimoto J., and Kasayama S. Relationship between circulating vascular cell adhesion molecule-1 and microvascular complications in type 2 diabetes mellitus. Diabetic Medicine 15 (1998) 661-667
26. Koivisto V.A., Stevens L.K., Mattock M., et al. Cardiovascular disease and its risk factors in IDDM in Europe. Diabetes Care 19 (1996) 689-697
27. Malik I., Danesh J., Whincup P., et al. Soluble adhesion molecules and prediction of coronary heart disease: A prospective study and meta-analysis. Lancet 358 (2001) 971-975
28. Matsumoto K., Sera Y., Ueki Y., et al. Comparison of serum concentrations of soluble adhesion molecules in diabetic microangiopathy and macroangiopathy. Diabetic Medicine 19 (2002) 822-826
29. Mehta J.L. Inflammatory and infectious basis of atherosclerosis (2001), Birkhauser Verlag, Basel, Switzerland [280 pp]
30. Olson J.A., Whitelaw C.M., McHardy K.C., Pearson D.W., and Forrester J.V. Soluble leucocyte adhesion molecules in diabetic retinopathy stimulate retinal capillary endothelial cell migration. Diabetologia 40 (1997) 1166-1171
31. Otsuki M., Hashimoto K., Morimoto Y., Kishimoto T., and Kasayama S. Circulating vascular cell adhesion molecule-1 (VCAM-1) in atherosclerotic NIDDM patients. Diabetes 46 (1997) 2096-2101
32. Pradhan A.D., Rifai N., and Ridker P.M. Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men. Circulation 106 (2002) 820-825
33. Ribau J.C., Hadcock S.J., Teoh K., DeReske M., and Richardson M. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients. The Journal of Surgical Research 85 (1999) 225-233
34. Richardson M., Hadcock S.J., DeReske M., and Cybulsky M.I. Increased expression in vivo of VCAM-1 and E-selectin by the aortic endothelium of normolipemic and hyperlipemic diabetic rabbits. Arteriosclerosis and Thrombosis 14 (1994) 760-769
35. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362 (1993) 801-809
36. Schmidt A.M., Crandall J., Hori O., Cao R., and Lakatta E. Elevated plasma levels of vascular cell adhesion molecule-1 (VCAM-1) in diabetic patients with microalbuminuria: A marker of vascular dysfunction and progressive vascular disease. British Journal of Haematology 92 (1996) 747-750
37. Schram M.T., Chaturvedi N., Schalkwijk C., et al. Vascular risk factors and markers of endothelial function as determinants of inflammatory markers in type 1 diabetes: The EURODIAB prospective complications study. Diabetes Care 26 (2003) 2165-2173
38. Smulders R.A., Stehouwer C.D., Schalkwijk C.G., et al. Distinct associations of HbA1c and the urinary excretion of pentosidine, an advanced glycosylation end-product, with markers of endothelial function in insulin-dependent diabetes mellitus. Thrombosis and Haemostasis 80 (1998) 52-57
39. Stehouwer C.D., Gall M.A., Twisk J.W., et al. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: Progressive, interrelated, and independently associated with risk of death. Diabetes 51 (2002) 1157-1165
40. Steiner M., Reinhardt K.M., Krammer B., Ernst B., and Blann A.D. Increased levels of soluble adhesion molecules in type 2 (non-insulin dependent) diabetes mellitus are independent of glycaemic control. Thrombosis and Haemostasis 72 (1994) 979-984
41. Sugiuchi H., Uji Y., Okabe H., et al. Direct measurement of high-density lipoprotein cholesterol in serum with polyethylene glycol-modified enzymes and sulfated alpha-cyclodextrin. Clinical Chemistry 41 (1995) 717-723